Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE13043.8083.8 (+0.65 %)

PREV CLOSE ( ) 12960.00

OPEN PRICE ( ) 13125.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3203

TODAY'S LOW / HIGH ( )12863.85 13280.00

52 WK LOW / HIGH ( )10060 19748.4

NSE13056.0096 (+0.74 %)

PREV CLOSE( ) 12960.00

OPEN PRICE ( ) 12997.00

BID PRICE (QTY) 13056.00 (187)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 39031

TODAY'S LOW / HIGH( ) 12823.00 13296.00

52 WK LOW / HIGH ( )10190.7 19747

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

4397.09

5142.73

2927.53

3283.6

Total Expenditure

3625.76

3587.27

2582.64

2772.87

PBIDT (Excl OI)

771.33

1555.46

344.89

510.73

Other Income

80.52

78.56

74.64

Operating Profit

851.86

1573.46

423.45

585.37

Interest

67.9

53.67

45.85

23.47

Exceptional Items

PBDT

783.96

1519.79

377.6

561.9

Depreciation

239.2

225.42

201.9

168.92

Profit Before Tax

544.76

1294.37

175.7

392.98

Tax

139.03

325.82

36.71

114.93

Provisions and contingencies

Profit After Tax

405.73

968.54

138.99

278.05

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

405.73

968.54

138.99

278.05

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

405.72

968.54

139

278.06

Equity Capital

129

129.01

129

Face Value (IN RS)

Reserves

Calculated EPS

31.45

75.07

10.77

21.55

Calculated EPS (Annualised)

125.80

300.29

43.09

86.22

No of Public Share Holdings

8642905

8641905

8637705

% of Public Share Holdings

67.37

67.36

67.32

PBIDTM% (Excl OI)

17.54

30.24

11.78

15.55

PBIDTM%

19.37

30.59

14.46

17.82

PBDTM%

17.82

29.55

12.89

17.11

PBTM%

12.38

25.16

6.00

11.96

PATM%

9.22

18.83

4.74

8.46

Notes

Risk Disclosures on Derivatives

Quarterly Results

NEULAND LABORATORIES LTD.